US 12102619
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
granted A61KA61K2236/15A61K2236/17
Quick answer
US patent 12102619 (Methods of treating tuberous sclerosis complex with cannabidiol and everolimus) held by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
- Grant date
- Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2236/15, A61K2236/17, A61K2236/333, A61K2236/37